Log in

CVE:VPT - VentriPoint Diagnostics Stock Price, Forecast & News

Today's Range N/A
50-Day Range
MA: C$0.09
52-Week Range N/A
Volume15,100 shs
Average Volume182,396 shs
Market CapitalizationC$6.87 million
P/E RatioN/A
Dividend YieldN/A
Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease primarily in Canada, the Unites States, and China. The company offers Ventripoint Medical System, medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides a suite of applications for various heart diseases and imaging modalities, including congenital heart diseases, left or right heart failure, and normal hearts. The company was incorporated in 2005 and is headquartered in Toronto, Canada.

Industry, Sector and Symbol

Industry Diagnostics & Research



Sales & Book Value

Annual SalesC$49,523.00
Book ValueC($0.04) per share



Market CapC$6.87 million
Next Earnings DateN/A
OptionableNot Optionable

Receive VPT News and Ratings via Email

Sign-up to receive the latest news and ratings for VPT and its competitors with MarketBeat's FREE daily newsletter.

VentriPoint Diagnostics (CVE:VPT) Frequently Asked Questions

What is VentriPoint Diagnostics' stock symbol?

VentriPoint Diagnostics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VPT."

Has VentriPoint Diagnostics been receiving favorable news coverage?

News stories about VPT stock have been trending very negative this week, InfoTrie reports. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. VentriPoint Diagnostics earned a news impact score of -3.6 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for VentriPoint Diagnostics.

Who are some of VentriPoint Diagnostics' key competitors?

What other stocks do shareholders of VentriPoint Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VentriPoint Diagnostics investors own include Resverlogix (RVX), Kootenay Silver (KTN), ProMetic Life Sciences (PLI), Radient Technologies (RTI), Pioneering Technology (PTE), Photon Control (PHO), OrganiGram (OGI), Mason Graphite (LLG), Canada Jetlines (JET) and Arianne Phosphate (DAN).

Who are VentriPoint Diagnostics' key executives?

VentriPoint Diagnostics' management team includes the folowing people:
  • Dr. George Adams, CEO & Director (Age 68)
  • Mr. Desmond Hirson, Pres
  • Ms. Ellen Briant, CFO & Corp. Sec.
  • Dr. Alvira Macanovic Ph.D., VP of Devel. & Operations
  • Ms. Jessica Naman, Marketing Mang.

How do I buy shares of VentriPoint Diagnostics?

Shares of VPT and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How big of a company is VentriPoint Diagnostics?

VentriPoint Diagnostics has a market capitalization of C$0.00 and generates C$49,523.00 in revenue each year. View Additional Information About VentriPoint Diagnostics.

What is VentriPoint Diagnostics' official website?

The official website for VentriPoint Diagnostics is http://www.ventripoint.com/.

How can I contact VentriPoint Diagnostics?

The company can be reached via phone at 416-848-4156.

MarketBeat Community Rating for VentriPoint Diagnostics (CVE VPT)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  18 (Vote Outperform)
Underperform Votes:  13 (Vote Underperform)
Total Votes:  31
MarketBeat's community ratings are surveys of what our community members think about VentriPoint Diagnostics and other stocks. Vote "Outperform" if you believe VPT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VPT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Featured Article: Monthly Dividend Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel